Phospho-Tau (Thr181) Antibody | Cell Signaling Technology
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Phospho-TAU (Thr181) cellular HTRF kit | Cisbio
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. - Abstract - Europe PMC
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays | Neurology
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression | Alzheimer's Research & Therapy | Full Text
Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer's | ALZFORUM
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis - Karikari - 2021 - Alzheimer's & Dementia - Wiley Online Library
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Plasma pTau181 as a biomarker for Alzheimer's disease - Meng - 2020 - MedComm - Wiley Online Library
Associations of plasma p-tau181 baseline levels and longitudinal... | Download Scientific Diagram
Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease | EMBO Molecular Medicine
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration | Nature Medicine
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease | Alzheimer's Research & Therapy | Full Text
Frontiers | Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study - The Lancet Neurology
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals | medRxiv
Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients | mdCurrent India
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease | PLOS ONE
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative | Molecular Psychiatry
